Expanding the Scope of our Research
In 2017, we began a partnership with the SASS Foundation for Medical Research and the Leukemia & Lymphoma Society to jointly support $1.2 million in new translational research over a 3-year period. Through this partnership, we are funding studies in chemotherapy-free treatment strategies with the potential to greatly improve therapy for hairy cell leukemia. Both researchers are conducting clinical trials for which they are actively seeking patients. Learn more on our clinical trials page.
Dr. Jae Park, Memorial Sloan Kettering Cancer Center, USA
Dr. Enrico Tiacci, University of Perugia, Italy